Bonneterre J, Buzdar A, Nabholtz JM, et al.Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Cancer.2001;92(9):2247-2258.
2.
Coleman RE.Should bisphosphonates be the treatment of choice for metastatic bone disease?Semin Oncol. 2001;28(4 Suppl 11):35-41.
3.
Wiesenthal LM, Su YZ, Duarte TE, Nagourney RA.Nonclonogenic, in vitro assays for predicting sensitivity to cancer chemotherapy. Prog Clin Biol Res. 1988;276:75-92.
4.
Villalona-Calero MA, Blum JL, Jones SE, et al.A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients. Ann Oncol. 2001;12(5):605-614.
5.
Crown J.Nonanthracycline containing docetaxel-based combinations in metastatic breast cancer. Oncologist. 2001;6 (suppl3):17-21
6.
Laufman LR, Spiridonidis CH, Pritchard J, et al.Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trial. Ann Oncol. 2001;12(9):1259-1264.
7.
Slamon DJ, Leyland-Jones B, ShakS, et al.Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med. 2001; 344(11):783-792.
8.
Chlebowski RT, Bulcavage L, Grosvenor M, et al.Hydrazine sulfate influence on nutritional status and survival in non-small-cell lung cancer. J Clin Oncol. 1990;8(1):9-15.
9.
Boik J. Cancer and Natural Medicine. Princeton Minn: Oregon Medical Press; 1998.
10.
Howe LR, Subbaramaiah K, Brown AM, Dannenberg AJ.Cyclooxygenase-2: a target for the prevention and treatment of breast cancer. Endocr Relat Cancer. 2001;8(2):97-114.
11.
Bihari B.LDN and cancer. Available at: www.lowdosenaltrexone.org. Accessed January 22, 2002.
12.
Brem S.Angiogenesis and cancer control: from concept to therapeutic trial. Cancer Control. 1999;6(5):436-458.
13.
Brewer GJ, Dick RD, Grover DK, et al.Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clin Cancer Res. 2000;6(1):1-10
14.
TemoshokL, Dreher H.The Type C Connection: The Behavioral Links to Cancer and Your Health. New York: Random House; 1992.
15.
Spiegel D, Bloom JR, Kraemer HC, Gottheil E.Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet. 1989; 2(8668):888-891.
16.
Goodwin PJ, Leszcz M, Ennis M, et al.The effect of group psychosocial support on survival in metastatic breast cancer. N Engl J Med. 2001;345(24):1719-1726.
17.
Levin JS.How religion influences morbidity and health: reflections on natural history, salutogenesis and host resistance. Soc Sci Med. 1996;43(5):849-864.